References
- Pan T, Kondo S, Zhu W, Xie W, Jankovic J, Le W. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiology of Disease. 2008;32:16–25. https://doi.org/10.1016/j.nbd.2008.06.003
-
Bae NY, Yang HO, Ahn TW. Protection effect of New-Yeolda-Hanso tang against
$\beta$ -Amyloid Induced Cytotoxicity in NGF-differentiated PC12 Cells. J Sasang Constitut Med. 2009;21:138-153. (Korean) - Bae NY, Ahn TK, Chung SK, Oh MS, Ko HS, Oh HG et al. The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease. Journal of Ethnopharmacology. 2011;134:313-322. https://doi.org/10.1016/j.jep.2010.12.016
- Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003;39:889-909. https://doi.org/10.1016/S0896-6273(03)00568-3
- Pan T, Kondo S, Le W and Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain. 2008;131: 1969-1978. https://doi.org/10.1093/brain/awm318
- Lee J. A. Neuronal Autophagy: A Housekeeper or a Fighter in Neuronal Cell Survival?. 2012;21:1-8. https://doi.org/10.5607/en.2012.21.1.1
- Hara T, Nakamura K, Matsui1 M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441-15.
- Pan T, Rawal P, Wu Y, Xie W, Jankovic J, Le W. Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neuroscience. 2009;164: 541–551. https://doi.org/10.1016/j.neuroscience.2009.08.014
- National federation of department of sasang constitutional medicine, colleges of oriental medicine. Sasang constitutional medicine. 2nd Ed. Seoul:Jipmoondang. 2004:419-421.
- Song IB. The Clinical Study on the Effect of Sasang Constitutional Medical Theraphy for Stroke. J Sasang Constitut Med. 1996;8(2):117-130. (Korean)
- Eisenberg-Lerner A, Bialik s, Simon H-U, Kimchi A. Life and death partners : apoptosis, autophagy and the cross-talk between them. Cell Death and Differentiation. 2009;16:966-975. https://doi.org/10.1038/cdd.2009.33
- Mauthe M, Jacob A, Freiberger S, Hentschel K, Stierhof Y. D, Codogno P et al. Resveratrol-mediated autophagy requires WIPI-1-regulated LC3 lipidation in the absence of induced phagophore formation. Autophagy. 2011;1448-1461.
- Underwood B. R, Imarisio S, Fleming A, Rose C, Krishna G, Heard P et al. Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease. Human Molecular Genetics. 2010;17:3413–3429.
- Kim HS, Choi JS, Ryu JH, Park SG, Cho SY, Park BC et al. Activation of autophagy during glutamate-induced HT22 cell death. Biochemical and Biophysical Research Communications. 2009;388:339–344. https://doi.org/10.1016/j.bbrc.2009.08.007
- Shin HY, Chu SH, Lee HK, Lee JW. mTOR Inhibitor as a Potential Drug of Age-related Disease. Korean J Clin Geri. 2011;12:149-159.
- Liang J, Shao S. H, ZX X. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol. 2007;9:218-24. https://doi.org/10.1038/ncb1537
- Williams T, Forsberg L. J, Viollet B., Brenman J. E. Basal autophagy induction without AMP-activated protein kinase under low glucose conditions. Autophagy. 2009;5:1155-1165. https://doi.org/10.4161/auto.5.8.10090
- Wu Y, Li X, Zhu J. X, Xie W, Le W, Fan Z et al. Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson's Disease. Neurosignals. 2011;19:163-174. https://doi.org/10.1159/000328516
- Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18:1926-45. https://doi.org/10.1101/gad.1212704
- Slomovitz B. M, Coleman R. L. The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer. Clin Cancer Res. 2012;21:5856-64.
- Jaclyn L. P, Gideon M. B, Wendy B. B, Phillip A. D. Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations. Drug Resistance Updates. 2008;32-50.
- Sebastian A, Antje S. L, Sebastian W, Bjorn S. Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks. MCB. 2011;06159-11.
- Qin L, Wang Z, Tao L, Wang Y. ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy. Autophagy. 2010;(2):239-47.
- Pan T, Rawal P, Wu Y, Xie W, Jankovic J, Le W. Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neuroscience. 2009;164: 541–551. https://doi.org/10.1016/j.neuroscience.2009.08.014
- Wang R. C, Wei Y, An Z, Zou Z, Xiao G, Bhagat G et al. Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science. 2012;338(6109):956-9. https://doi.org/10.1126/science.1225967
- Ralph A, Nixon, Yang D. S. Autophagy failure in Alzheimer's disease-locating the primary defect. Neurobiology of Disease. 2011;43:38-45. https://doi.org/10.1016/j.nbd.2011.01.021
- Alirezaei M, Kemball C. C, Flynn C. T, Wood M. R, Whitton J. L., Kiosses W. B. hort-term fasting induces profound neuronal autophagy. Autophagy. 1998;6:702-710.
- Dadakhujaev S, Noh HS, Jung EJ, Cha JY, Baek SM, Ha JH et al. Autophagy protects the rotenone-induced cell death in alpha-synuclein overexpressing SH-SY5Y cells. Neuroscience Letters. 2010;472:47–52. https://doi.org/10.1016/j.neulet.2010.01.053
- Wilms H, Zecca L, Rosenstiel P, Sievers J, Deuschl G, Lucius R. Imflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr Pharm Des. 2007;13:1925-8. https://doi.org/10.2174/138161207780858429
- Ravikumar B, Berger Z, Vacher C, O'Kane C. J, Rubinsztein D. C. Rapamycin pre-treatment protects against apoptosis. Human Molecular Genetics. 2008;7:1209-1216. https://doi.org/10.4238/vol7-4gmr484
- Cell signaling Technology (http://www.cellsignal.com/ pathways/autophagy-signaling.jsp)
Cited by
- Neuroprotective Effects of Modified Yuldahanso-tang (MYH) in a Parkinson's Disease Mouse Model vol.27, pp.2, 2015, https://doi.org/10.7730/JSCM.2015.27.2.270